Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-19-262830
Filing Date
2019-10-04
Accepted
2019-10-04 16:59:01
Documents
7

Document Format Files

Seq Description Document Type Size
1 POS AM d768866dposam.htm POS AM 444891
2 EX-1.2 d768866dex12.htm EX-1.2 181289
3 EX-5.1 d768866dex51.htm EX-5.1 36368
4 EX-23.1 d768866dex231.htm EX-23.1 1388
5 GRAPHIC g768866g04p74.jpg GRAPHIC 36399
6 GRAPHIC g768866g77r46.jpg GRAPHIC 37573
7 GRAPHIC g768866snap0001.jpg GRAPHIC 1731
  Complete submission text file 0001193125-19-262830.txt   769402
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-229091 | Film No.: 191139090
SIC: 2834 Pharmaceutical Preparations